Pages that link to "Q72506070"
Jump to navigation
Jump to search
The following pages link to Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial (Q72506070):
Displaying 50 items.
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data) (Q24243900) (← links)
- Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer (Q26773664) (← links)
- Muscle-invasive urothelial bladder cancer: an update on systemic therapy (Q26775780) (← links)
- Multimodal management of muscle-invasive bladder cancer (Q27011624) (← links)
- Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial (Q33419283) (← links)
- The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. (Q34039879) (← links)
- Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer (Q34108003) (← links)
- ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy (Q34278209) (← links)
- Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC) (Q34337059) (← links)
- Current perspectives in muscle invasive bladder cancer (Q34548563) (← links)
- Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy (Q34816825) (← links)
- The role of systemic chemotherapy in the management of muscle-invasive bladder cancer (Q35021331) (← links)
- Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder (Q35125750) (← links)
- Progress in personalizing chemotherapy for bladder cancer (Q35779460) (← links)
- Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents (Q35990617) (← links)
- Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials (Q36104937) (← links)
- The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy (Q36111241) (← links)
- Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting (Q36474159) (← links)
- Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. (Q36729145) (← links)
- Radiotherapy for bladder cancer (Q36729153) (← links)
- The role of chemotherapy in upper tract urothelial carcinoma (Q37071515) (← links)
- Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. (Q37171971) (← links)
- Treatment of locally advanced and metastatic bladder cancer (Q37197514) (← links)
- Perioperative chemotherapy for muscle-invasive bladder cancer. (Q37472550) (← links)
- Comprehensive surgical and chemotherapy treatment for invasive bladder cancer (Q37680034) (← links)
- Current chemotherapeutic strategies against bladder cancer (Q37888549) (← links)
- Neoadjuvant chemotherapy for invasive bladder cancer (Q37982318) (← links)
- Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review (Q38051010) (← links)
- Chemotherapy for Muscle-Invasive Bladder Cancer. (Q38711504) (← links)
- Landmarks in the treatment of muscle-invasive bladder cancer (Q39413207) (← links)
- Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. (Q39855461) (← links)
- Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma. (Q40881815) (← links)
- Chemotherapy for invasive bladder cancer (Q40991568) (← links)
- Dr. North's rebuttal. (Q41264148) (← links)
- Perioperative chemotherapy: the case for adjuvant chemotherapy for muscle-invasive bladder cancer (Q41264196) (← links)
- Cystectomy and urinary diversion (Q41564545) (← links)
- Systemic chemotherapy of transitional cell carcinoma of the urothelium (Q41564562) (← links)
- What is the role of adjuvant chemotherapy in locally advanced and lymph node-positive bladder cancer after radical cystectomy? (Q42039017) (← links)
- Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma (Q43294213) (← links)
- A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. (Q43719040) (← links)
- Survival in patients treated with radical cystectomy for bladder carcinoma (Q43861990) (← links)
- Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy (Q44426851) (← links)
- Adjuvant chemotherapy in lymph node positive bladder cancer (Q46623459) (← links)
- Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials (Q47137922) (← links)
- Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment. (Q47788273) (← links)
- Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017. (Q49526759) (← links)
- Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. (Q51939874) (← links)
- Update on chemotherapy in the treatment of urothelial carcinoma (Q58694390) (← links)
- Actualización de las Guías Clínicas de la Asociación Europea de Urología sobre el carcinoma vesical músculo-invasivo y metastásico (Q60657203) (← links)
- Adjuvant chemotherapy in muscle-invasive bladder carcinoma (Q61899595) (← links)